Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial).Saverio Cinieri, Uğur Çoşkun, Kadri Altundağ et al.|Journal of Clinical Oncology|2014Cited by 3